ProMIS Neurosciences, Inc.
PMN
$0.52
$0.0193.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 94.36% | 124.46% | 61.66% | -39.50% | -65.15% |
| Gross Profit | -94.36% | -124.46% | -61.66% | 39.50% | 65.15% |
| SG&A Expenses | -210.46% | 36.03% | -42.57% | 6.33% | -22.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -35.42% | 76.15% | -6.42% | -26.03% | -54.54% |
| Operating Income | 35.42% | -76.15% | 6.42% | 26.03% | 54.54% |
| Income Before Tax | 93.35% | 492.94% | -13.48% | 26.70% | 50.72% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 93.35% | 492.94% | -13.48% | 26.70% | 50.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 93.35% | 492.94% | -13.48% | 26.70% | 50.72% |
| EBIT | 35.42% | -76.15% | 6.42% | 26.03% | 54.54% |
| EBITDA | 35.25% | -75.97% | 6.56% | 26.12% | 54.74% |
| EPS Basic | 96.28% | 261.95% | 50.76% | 67.81% | 78.81% |
| Normalized Basic EPS | 151.18% | 261.86% | 50.77% | 67.81% | 78.80% |
| EPS Diluted | 96.28% | 261.95% | 50.76% | 67.81% | 78.81% |
| Normalized Diluted EPS | 151.18% | 261.61% | 50.77% | 67.81% | 78.80% |
| Average Basic Shares Outstanding | 77.78% | 142.70% | 130.45% | 127.69% | 132.50% |
| Average Diluted Shares Outstanding | 77.78% | 143.05% | 130.45% | 127.69% | 132.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |